Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Dow
AstraZeneca
Johnson and Johnson
Boehringer Ingelheim
McKesson

Last Updated: November 28, 2022

CLINICAL TRIALS PROFILE FOR ULORIC


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Uloric

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00102440 ↗ Febuxostat Versus Allopurinol Control Trial in Subjects With Gout Completed Takeda Phase 3 2002-07-01 The purpose of this study is to evaluate the safety and efficacy of febuxostat, once daily (QD), versus allopurinol in subjects with gout.
NCT00174915 ↗ Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects. Completed Takeda Phase 3 2003-02-01 The purpose of this study is to compare febuxostat, allopurinol and placebo, once daily (QD), in subjects with gout.
NCT00174941 ↗ Long-Term Safety of Febuxostat in Subjects With Gout. Completed Takeda Phase 2 2001-03-01 The purpose of this study is to evaluate the long-term safety of febuxostat, once daily (QD), in maintaining serum urate levels within clinically acceptable levels in subjects with gout.
NCT00174967 ↗ Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout Completed Takeda Phase 2 2001-01-01 The purpose of this study is to determine the efficacy of febuxostat, once daily (QD), in reducing serum urate levels in subjects with gout.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Uloric

Condition Name

Condition Name for Uloric
Intervention Trials
Gout 14
Hyperuricemia 5
Chronic Kidney Disease 3
Hypertension 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Uloric
Intervention Trials
Hyperuricemia 9
Gout 9
Renal Insufficiency, Chronic 3
Kidney Diseases 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Uloric

Trials by Country

Trials by Country for Uloric
Location Trials
United States 276
Mexico 8
Canada 6
China 3
Iceland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Uloric
Location Trials
California 11
Texas 11
Florida 10
North Carolina 9
Oklahoma 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Uloric

Clinical Trial Phase

Clinical Trial Phase for Uloric
Clinical Trial Phase Trials
Phase 4 5
Phase 3 6
Phase 2 11
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Uloric
Clinical Trial Phase Trials
Completed 23
Terminated 2
Unknown status 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Uloric

Sponsor Name

Sponsor Name for Uloric
Sponsor Trials
Takeda 15
Shanghai 10th People's Hospital 2
GenX Laboratories Inc. 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Uloric
Sponsor Trials
Industry 20
Other 19
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
McKinsey
Merck
AstraZeneca
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.